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Background: Accruing evidence suggests that positive imagery-based cognitive bias modiﬁcation (CBM)
could have potential as a standalone targeted intervention for depressive symptoms or as an adjunct to
existing treatments. We sought to establish the beneﬁt of this form of CBM when delivered prior to
Internet cognitive behavioral therapy (iCBT) for depression
Methods: A randomized controlled trial (RCT) of a 1-week Internet-delivered positive CBM vs. an active
control condition for participants (N¼75, 69% female, mean age¼42) meeting diagnostic criteria for
major depression; followed by a 10-week iCBT program for both groups.
Results: Modiﬁed intent-to-treat marginal and mixed effect models demonstrated no signiﬁcant
difference between conditions following the CBM intervention or the iCBT program. In both conditions
there were signiﬁcant reductions (Cohen's d .57–1.58, 95% CI¼ .12–2.07) in primary measures of
depression and interpretation bias (PHQ9, BDI-II, AST-D). Large effect size reductions (Cohen's d .81–
1.32, 95% CI¼ .31–1.79) were observed for secondary measures of distress, disability, anxiety and
repetitive negative thinking (K10, WHODAS, STAI, RTQ). Per protocol analyses conducted in the sample
of participants who completed all seven sessions of CBM indicated between-group superiority of the
positive over control group on depression symptoms (PHQ9, BDI-II) and psychological distress (K10)
following CBM (Hedges g .55–.88, 95% CI¼ .03–1.46) and following iCBT (PHQ9, K10). The majority
(470%) no longer met diagnostic criteria for depression at 3-month follow-up.
Limitations: The control condition contained many active components and therefore may have repre-
sented a smaller ‘dose’ of the positive condition.
Conclusions: Results provide preliminary support for the successful integration of imagery-based CBM
into an existing Internet-based treatment for depression.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Depression is a global health problem, estimated to become the
leading cause of burden of disease worldwide by 2030 (World
Health Organization, 2008). The limitations in efﬁcacy and acces-
sibility of current treatments for depression have led to increasing
recognition of the need for treatment innovation, such as devel-
opment of easier to access, and more cost-effective psychological
therapies (Simon and Ludman, 2009). Cognitive science provides
one promising avenue for such work (Holmes et al., 2014).
Research has begun to demonstrate that simple emotion training
computerized procedures, known as cognitive bias modiﬁcation
(CBM; Macleod, 2012) may be used to selectively target biases
implicated the onset, maintenance, and recurrence of depression.
The CBM paradigm most often researched in depression
focuses on two cognitive targets; mental imagery and interpreta-
tion. Participants repeatedly practice imagining positive resolu-
tions for ambiguous situations, and through this imagery CBM
aims to train a bias to automatically imagine positive resolutions
for novel ambiguous situations encountered in daily life.
Depressed individuals struggle to imagine positive future events
(Holmes et al., 2008; Morina et al., 2011) and tend to interpret
ambiguous information negatively rather than positively – a
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negative interpretation bias (Butler and Mathews, 1983). Training
positive mental imagery (via repeated positive imagery genera-
tion) in conjunction with positive interpretation (via consistently
positive resolutions of the ambiguous situations; cf. Mathews and
Mackintosh, 2000) may therefore be particularly helpful in redu-
cing symptoms of depression, via targeting these particular
processes synergistically (Holmes et al., 2009a). Experimental
studies have demonstrated that a single session of imagery CBM
could increase positive affect and positive interpretation in healthy
volunteers (e.g., Holmes et al., 2009b, 2006). Subsequent preli-
minary studies in clinical samples found reductions in symptoms
of depression and negative interpretation following a one-week
schedule of seven CBM sessions (Blackwell and Holmes, 2010;
Lang et al., 2012; Torkan et al., 2014).
One possible therapeutic deployment of such a brief treatment
module would be to combine CBM with existing evidence-based
computerized treatments such as Internet cognitive behavioral
therapy (iCBT; Andersson, 2009). While both CBM and iCBT aim to
change negative cognitive biases, they do so via different methods:
iCBT via explicit ‘top down’ cognitive evaluation and behavioral
experiments, and CBM via a potentially more direct ‘bottom up’
cognitive training approach. While there are several ways in which
these two approaches could be combined, one possibility is that
positive imagery CBM may provide a useful preparatory treatment
module prior to engaging in iCBT. For example, the trained
interpretive bias may make it easier to generate alternative
thoughts. Further, repeated practice in imagining positive out-
comes for activities during CBM may facilitate anticipation of
positive outcomes from behavioral tasks during iCBT. Such
increased positive anticipation could potentially have more gen-
eralized beneﬁts, such as increased interest in everyday activities
more broadly, which may be beneﬁcial in particular for reducing
anhedonic symptoms of depression (Blackwell et al., 2015).
In the ﬁrst trial to evaluate a combined positive imagery CBM
plus iCBT intervention we (Williams et al., 2013b) randomized
patients diagnosed with a major depressive episode to an 11-week
intervention (CBMþ iCBT) or a wait-list control (WLC). Results
supported treatment superiority over WLC on all outcome mea-
sures (Hedges g¼ .74–.98, 95% CI .11–1.62). Results also demon-
strated that the putative causal mechanism, change in
interpretation bias, at least partially accounted for the reduction
in depression symptoms following CBM. Further, 65% of patients
who completed the combined intervention evidenced clinically
signiﬁcant change (reaching high end-state functioning).
This ﬁrst trial provided encouraging results of the integration of
two Internet-based technologies into an efﬁcacious and acceptable
form of treatment delivery for major depression. However, the
comparison group was a wait-list control. In the current RCT we
aimed to carry out a more rigorous test of CBM via comparison to a
closely-matched active control condition (i.e., exposed to identical
intervention procedures minus one or more of the hypothesized active
treatment ingredients; cf. Clarke et al., 2014b). Following Lang et al.
(2012), we used a control condition in which only one of the putative
active ingredients was removed. Speciﬁcally, the control conditionwas
identical to the positive imagery CBM, except that no valence-speciﬁc
training contingency was established: only half of the ambiguous
training scenarios were resolved positively, whereas the rest were
resolved negatively. To test the additive beneﬁt of positive imagery
CBM when delivered in combination with iCBT, all patients completed
an established iCBT program for depression following the 1-week CBM
intervention.
1.1. Hypotheses
We predicted that patients randomized to positive imagery CBM
(positive condition) would evidence signiﬁcant reductions on primary
measures of depressive symptoms (PHQ9, BDI-II) and interpretive bias
(AST-D), and on a secondary measure of psychological distress (K10)
following the 1-week CBM intervention. We predicted superiority of
positive imagery CBM over CBM control (control condition) on these
measures following the 1-week intervention phase. We also predicted
signiﬁcant reductions on measures of depression (PHQ9, BDI-II,) and
psychological distress (K10), as well as disability (WHODAS), repetitive
negative thinking (RTQ), and anxiety (STAI) following completion of
iCBT. Although we anticipated comparable outcomes following com-
pletion of iCBT, as the ﬁrst study to investigate the potential additive
beneﬁt of positive imagery CBM prior to iCBT (relative to an active
comparator), we tested for between-group superiority of the positive
condition on measures of depression and distress following the
combined intervention. Following a recent RCT in which a four-week
positive imagery CBM intervention signiﬁcantly reduced anhedonic
symptoms of depression compared to an active control (in the absence
of between-group differences for symptoms of depression as a whole
(Blackwell et al., 2015)), we carried out post-hoc analyses to investi-
gate whether we could also ﬁnd signiﬁcant beneﬁts for anhedonia.
Finally, we predicted that the within-group beneﬁts would be main-
tained at 3-month follow-up.
2. Methods
2.1. Participants and recruitment
The minimum sample size for each group (alpha set at .05,
power at .80) was identiﬁed as 29, following a power calculation
using a between-group effect corresponding to Hedges's g of .66
(Lang et al., 2012), but an additional 10% was recruited to hedge
against attrition. Recruitment was via the research arm of a not-
for-proﬁt clinical and research unit afﬁliated with St. Vincent's
Hospital and the University of New South Wales, Australia that
specializes in the development and evaluation of Internet-CBT.
Applicants ﬁrst completed online screening questionnaires asses-
sing symptoms and demographic details (see Fig. 1: Participant
Flowchart for inclusion and exclusion criteria). Applicants who
passed this screening phase were telephoned for a diagnostic
interview using the Mini International Neuropsychiatric Interview
Version 5.0.0 (M.I.N.I; Sheehan et al., 1998) to determine whether
they met diagnostic criteria for a major depressive episode. A
registered psychologist trained in administration of the M.I.N.I
conducted all interviews. Participants were informed of the study
design and completed electronic informed consent prior to enroll-
ment. Eligible participants accepted into the study were rando-
mized based on an allocation sequence generated by an
independent person not involved in the study via a true rando-
mization process (www.random.org). Participants remained blind
to group allocation. They were offered one entry into a draw for a
gift card valued at $100 following completion of the 3-month
follow-up. Clinicians conducting follow-up interviews were blind
to patient information. The trial protocol (Williams et al., 2013a)
was approved by the Human Research Ethics Committee of St.
Vincent's Hospital and was prospectively registered on anzctr.org.
au (ACTRN12613000139774) and clinicaltrials.gov (NCT01787513).
2.2. Interventions
2.2.1. CBM program
Seven sessions of imagery CBM were completed daily online
over the course of one week. Each session was approximately
15–20 min in duration (see Blackwell and Holmes (2010) and
Williams et al. (2013b) for details). There were a total of 416
different training paragraphs, half recorded in a male voice and
half recorded in a female voice and adapted to Australian cultural
A.D. Williams et al. / Journal of Affective Disorders 178 (2015) 131–141132
norms (e.g., reference to ‘snow’ was replaced with ‘rain’). Partici-
pants listened the training paragraphs, with the instruction to
imagine themselves in the scenarios as if actively involved. The
potential outcome of all scenarios was initially ambiguous and
only resolved towards the end of the paragraph. In the positive
condition all scenarios had a positive or benign resolution, thus
establishing a learning contingency between the ambiguous start
and the imagined resolution. For example: ‘You ask a friend to look
over some work you have done. They come back with some
comments, which are all very positive’ (positive resolution in
italics). In the Control condition 50% of the scenarios had a positive
resolution and 50% had a negative resolution (e.g., ‘They come
back with some comments, which are all critical’), thus establishing
no valence-speciﬁc training contingency. Adherence to the CBM
program was monitored through the computer software. If a
participant missed a session, a member of the research team sent
Fig. 1. Study Flowchart.
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an email reminder via the Virtual Clinic system or made telephone
contact.
2.2.2. iCBT – The Sadness Program
The Sadness Program has been evaluated in four previous trials
(Perini et al., 2008, 2009; Titov et al., 2010; Watts et al., 2013), an
effectiveness study (Williams and Andrews, 2013), and has been
delivered as part of a routine clinical service in Australia since
2010 (see Andrews and Williams (In press)). The program consists
of six online lessons representing best practice CBT, as well as
regular homework assignments and access to supplementary
resources delivered over the course of 10 weeks. Each lesson was
designed using a cartoon narrative and included: psycho-educa-
tion, behavioral activation, cognitive restructuring, graded expo-
sure, problem solving, assertiveness skills, and relapse prevention.
Patient queries throughout the program were primarily addressed
by email contact from the Clinician (a doctoral level psychologist)
or the research support ofﬁcer. If clinically indicated, or if patients'
K10 and/or PHQ9 scores deteriorated, the Clinician would make
telephone contact.
2.3. Primary outcome measures
The Patient Health Questionnaire-9 (PHQ9; Kroenke et al., 2001)
and the Beck Depression Inventory—Second Edition (BDI-II; Beck
et al., 1996) were administered to assess depression symptoms
(α¼ .82 and .88, respectively). The Ambiguous Scenarios Test for
Depression (AST-D; Berna et al., 2011) provided an index of
interpretation bias (higher scores reﬂect a more positive bias).
Two versions of the AST-D (α¼ .78 and .79) were presented in
counterbalanced order (at baseline and following the 1-week CBM
intervention). The Kessler-10 Psychological Distress Scale (K10;
Kessler et al., 2002) measured non-speciﬁc psychological distress
(modiﬁed in the current study to assess distress in the past week;
α¼ .84). The PHQ9, BDI-II, and K10 were administered at baseline,
following the 1-week CBM intervention, following the combined
intervention (11 weeks), and at 3-month follow-up. Change in
diagnostic status was assessed using the M.I.N.I (Sheehan et al.,
1998) Depression Module administered via telephone at 3-month
follow-up.
2.4. Secondary outcome measures
The following secondary measures were collected at baseline,
after completion of the combined intervention, and at 3-month
follow-up. The 12-itemWorld Health Organisation Disability Assess-
ment Schedule (WHODAS-II; World Health Organization) measured
functional impairment and activity limitation (higher scores indi-
cate greater disability; α¼ .83). The Repetitive Thinking
Questionnaire-10 (RTQ-10; McEvoy et al., 2010) measured perse-
verative negative thinking (higher scores indicate greater rumina-
tion; current sample α¼ .88). The State Trait Anxiety Inventory-Trait
Version (STAI; Spielberger et al., 1983) was used to index trait
anxiety (higher scores indicative of greater anxiety; α¼ .82).
Comorbid Generalized Anxiety Disorder (GAD) and Social Phobia
(SP) status were assessed at baseline and at 3-month follow-up
with the M.I.N.I GAD and SP modules.
2.5. Additional measures
A Treatment Expectancy (adapted from Devilly and Borkovec
(2000)) and Outcomes Questionnaire was administered at baseline
(to assess how useful and logical participants expected the
program to be) and following the combined intervention (to assess
treatment satisfaction). The Prospective Imagery Task (PIT; Holmes
et al., 2008; Stöber, 2000) was administered at baseline to check
that groups were comparable for imagery ability (α¼ .85 for both
the positive and negative subscales). The Skills of Cognitive
Therapy-Patient Version (SoCT-P; Jarrett et al., 2011; α¼ .86) was
administered following the combined intervention to assess par-
ticipants use of cognitive strategies (higher scores reﬂect greater
patient skill in applying cognitive therapy principles and coping
strategies) and the association with depression symptom
reduction.
2.6. Statistical methods
Signiﬁcance testing of baseline group differences was con-
ducted using ANOVA and χ2 where the variables consisted of
nominal data. Efﬁcacy analyses were conducted via mixed model-
ing using restricted maximum likelihood (REML) estimation. A
linear mixed model for each outcome measure was implemented
using the MIXED procedure with a random intercept for subject.
As the random effect had one level, a variance components (VC)
covariance structure was speciﬁed to model the covariance struc-
ture of the intercept (with the exception of the model for AST-D
which required a diagonal structure). The effect of Group, Time,
and the Group by Time interaction term were entered in each
model. The between-group differences of interest were tested via
pairwise contrasts provided by the EMEANS command1. Per
protocol analyses of the primary hypotheses using data from
participants who completed all 7 sessions of the CBM program
were also conducted. Conservative effect size estimates were
calculated between-group (Hedges g, using the pooled standard
deviation and adjusting for sample size) and within-group
(Cohen's d, adjusting for the repeated measures correlation using
formula d¼tnSQRT[(2(lr)/n] (Dunlap et al., 1996)). Consistent
with previous research (Vernmark et al., 2010; Williams et al.,
2013b), clinically signiﬁcant change was deﬁned as high-end state
functioning (BDI-II scoreo14) combined with a total score reduc-
tion greater than the reliable change index score (RCI) of 7.16
(Jacobson and Truax, 1991). Due to the high rate of comorbid
anxiety disorders, clinically signiﬁcant change was also calculated
for the STAI-T based on a RCI of 7.86 in combination with a ﬁnal
score below the recommended cut-score of 45.7 (Fisher and
Durham, 1999). Analyses were performed in SPSS version 22.
3. Results
3.1. Group characteristics and adherence
The ﬁnal sample (after protocol speciﬁed exclusions and with-
drawals2) included 36 participants (69% female) randomized to the
positive condition and 39 participants (77% female) randomized to
the control condition. There were no group differences in any of
the demographic variables, all p4 .05 (see Table 1) or in baseline
measures or indices of treatment adherence, all to1.55, all p4 .05
(see Tables 1 and 2). Similar numbers completed all 7 sessions of
CBM (positive condition: n¼21, 58%; control: n¼25, 64%) and all
6 lessons of iCBT (positive condition: n¼25, 69%; control: n¼26,
67%). A small number of participants completed zero iCBT lessons
(positive condition: n¼4, 11%; control: n¼5, 13%).
1 All models included Time as a ﬁxed effect across all four indicated measure-
ment time-points; therefore our hypotheses were addressed via the between-
group contrasts rather than overall model effects.
2 The modiﬁed ITT analyses did not include participants who were formally
withdrawn for reasons pre-speciﬁed in the trial protocol. All other participants
were included, irrespective of adherence (see Footnote 4).
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3.2. Primary outcomes
Table 2 reports the results of the mixed-effects models. For
depression symptoms there was a main effect of Time for the
PHQ9, F(3, 205.59)¼29.50, po .001, and the BDI-II, F(3, 202.90)¼
52.22, po .001. There were no signiﬁcant main effects of Group or
Time by Group interactions, all Fo2, all p4 .05. For interpretation
bias there was a main effect of Time for the AST-D, F(1, 156.60)¼
24.24, p o .001, indicating a signiﬁcant increase in positive inter-
pretations in both groups. The main effect of Group, and the Time
by group interaction, was not signiﬁcant, Fo1, p4 .05.
3.3. Secondary outcomes
For psychological distress there was a main effect of Time for
the K10 (collected at all 4 time points-see Table 2), F(3, 202.42)¼
Table 1
Demographic and baseline characteristics, treatment expectancy, and adherence and treatment acceptability by condition.
Positive condition Control condition
(n¼36) (n¼39)
Gender
Female 25 (69%) 30 (77%)
Male 11 (31%) 9 (23%)
Age 43.94 (10.80) 39.86 (11.93)
Australia/New Zealand Born 29 (81%) 31 (79%)
English as Primary Language 34 (94%) 36 (92%)
Marital Status
Single 8 (22%) 16 (41%)
Married/Defacto 18 (50%) 12 (31%)
Separated/Divorced 5 (14%) 9 (23%)
Widowed 5 (14%) 2 (5%)
Work Status
Employed 17 (48%) 22 (56%)
Unemployed 3 (8%) 3 (8%)
Retired 3 (8%) 2 (5%)
Disability Pension 3 (8%) 5 (13%)
Other 10 (28%) 7 (18%)
Education
Year 10/12 Certiﬁcate 7 (20%) 12 (31%)
Trade/Technical Certiﬁcate 8 (22%) 4 (10%)
Undergraduate Diploma 6 (17%) 6 (15%)
Bachelor Degree 12 (33%) 14 (36%)
Master/Doctoral Degree 3 (8%) 3 (8%)
Current Antidepressant Medication
No 18 (50%) 18 (46%)
Yes 18 (50%) 21 (54%)
Comorbidity
None 14 (39%) 9 (23%)
Generalized Anxiety Disorder and Social Phobia 12 (33%) 12 (31%)
Generalized Anxiety Disorder 6 (17%) 13 (33%)
Social Phobia 4 (11%) 5 (13%)
Age First Depressive Episode 22.13 (10.87) 21.05 (11.30)
Number of Previous Depressive Episodes
0–1 1 (3%) 4 (10%)
2–3 4 (11%) 3 (8%)
Z 4 31 (86%) 32 (82%)
[M, SD] [M, SD]
Treatment Expectancy
Logical 3.22 (1.14) 3.56 (.96)
Useful 3.30 (.89) 3.11 (.85)
Number of CBM sessions completed 6.33 (.95) 6.30 (1.07)
Number of iCBT lessons completed 4.86 (2.07) 4.69 (2.20)
Prospective Imagery Task (PIT)
Positive subscale 23.66 (6.78) 23.30 (7.19)
Negative subscale 32.83 (7.42) 33.05 (9.08)
Feedback for CBM programa
Satisﬁed with of sessions 52% (n¼19) 51% (n¼20)
Reduce of sessions 42% (n¼15) 41% (n¼16)
Increase of sessions 5% (n¼2) 8% (n¼3)
Treatment satisfactiona
Dissatisﬁed/neutral 25% (n¼8) 29% (n¼10)
Mostly/very satisﬁed 75% (n¼24) 71% (n¼24)
Program qualitya
Unsatisfactory 3% (n¼1) 3% (n¼1)
Satisfactory 13% (n¼4) 17% (n¼6)
Good/Excellent 84% (n¼27) 80% (n¼27)
Conﬁdence recommending to friend 7.18 (1.95) 7.11 (2.04)
Access to iCBT content post-treatment 2.15 (.93) 2.18 (.72)
Note: Number of previous depressive episodes based on participant self-report. Conﬁdence recommending the program to a friend with depression rated 0–10. Access to
iCBT content post-treatment¼ frequency participants accessed the iCBT material after program completion (assessed at 3-month follow-up).
a % based on positive condition n¼32; control condition n¼34.
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Table 2
Observed means (standard deviations) for measures and within-group effect sizes in the full sample.
Baseline Mean
(SD)
Post-CBM Mean
(SD)
Within t(df) r Between t(df) Post-iCBT Mean
(SD)
Within t(df) r Between t(df) 3 Month Mean
(SD)
Within t(df) r Between t(df)
T1 T2 ES (95% CI) T1, T2 ES (95% CI) T1, T2 T3 ES (95% CI) T1, T3 ES (95% CI) T1,
T3
T4 ES (95% CI) T3, T4 ES (95% CI) T3,
T4
PHQ9
Positive
16.22 (5.34) 8.97 (5.95) 6.09 (3202.30)nn
r¼ .38
1.27 (1219.89) 8.68 (6.56) 5.96 (3206.16)nn
r¼ .49
.92 (1233.59) 9.21 (6.62) .32 (3204.78) r¼ .63 .92 (1233.59)
1.13 (.66–1.59) .27 ( .17 to .73) 1.06 (.56–1.55) .26 ( .22 to .74) .04 ( .44 to .52) .17 ( .31 to .65)
PHQ9 Control 15.33 (4.89) 10.74 (6.56) 4.01 (3202.30)nn
r¼ .53
10.35 (6.08) 4.28 (3206.96)nn
r¼ .15
8.06 (6.19) 1.59 (3207.72)
r¼ .27
.62 (.17–1.06) .96 (.48–1.43) .33 ( .15 to .81)
BDI-II
Positive
31.05 (8.48) 20.36 (7.82) 5.72 (3200.72)nn
r¼ .51
1.47 (1162.13) 15.50 (11.88) 7.76 (3203.29)nn
r¼ .65
1.15 (1178.72) 17.33 (12.70) .91 (3202.24) r¼ .60 1.15 (1178.72)
.94 (.47–1.40) .34 ( .11 to .80) 1.14 (.64–1.63) .32 ( .15 to .81) .14 ( .34 to .62) .25 ( .23 to .73)
BDI-II Control 31.84 (10.93) 24.15 (13.10) 4.28 (3200.72)nn
r¼ .65
19.23 (10.68) 6.79 (3203.87)nn
r¼ .42
14.06 (12.26) 2.03 (3203.19)
r¼ .37
.57 (.12–1.01) 1.25 (.77–1.72) .39 ( .09 to .87)
AST-D
Positive
3.75 (.95) 4.65 (.89) 3.83 (1141.48)nn
r¼ .38
.97 (173.00)
.71 (.24–1.17) .22 ( .23 to
.67)
AST-D
Control
3.59 (1.18) 4.45 (.91) 3.78 (1141.48)nn
r¼ .29
.72 (.27–1.16)
K10 Positive 30.36 (6.54) 25.13 (6.48) 4.54 (3200.37)nn
r¼ .65
1.23 (1155.05) 19.56 (6.87) 8.61 (3202.79)nn
r¼ .49
1.79 (1171.22) 22.12 (7.53) 2.01 (3201.78)
r¼ .59
1.79 (1171.22)
.63 (.16–1.09) .30 ( .14 to .76) 1.53 (1.03–2.02) .50 (.01–.99) .31 ( .17 to .79) .11 ( .37 to .59)
K10 Control 31.56 (6.30) 27.15 (6.50) 3.99 (3200.37)nn
r¼ .71
23.11 (7.09) 7.32 (3203.33)nn
r¼ .48
21.27 (7.73) 1.04 (3202.67)
r¼ .50
.48 (.03–.92) 1.28 (.69–1.64) .18 ( .30 to .66)
Note. T1¼Baseline, T2¼Post-CBM, T3¼Post-CBMþ iCBT, T4¼3-month follow-up. PHQ9¼Patient Health Questionnaire-9 item; BDI-II¼Beck Depression Inventory-2nd Edition; K10¼Kessler Distress Scale – 10 item; AST-
D¼Ambiguous Scenarios Test for Depression. Within-group ES¼Cohen's d based on the formula: d¼t*SQRT[2(lr)/n]. N T1: Positive¼36, Control¼39; T2: Positive¼36, Control¼39; T3: Positive¼32, Control¼34; T4:
Positive¼33, Control¼33.
nn po .001.
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54.81, po .001. For all remaining secondary outcome measures
(WHODAS, RTQ, STAI) separate linear mixed models were calcu-
lated with measurement occasion (3 time points) entered with a
random intercept for subject. For each secondary outcome there
was a main effect of Time, all F (2, 130.85–133.02)¼37.56–70.75,
all po .001. Observed means and effect sizes are reported in
Tables 2 and 3. There were no main effects of Group or Time by
Group interactions for any of the secondary outcome measures.
3.4. Per protocol analyses
The per protocol sample consisted of participants (n¼46) who
completed all 7 CBM sessions (i.e., our pre-deﬁned per protocol
criterion; Williams et al., 2013a, 2013b). There were no differences
between CBM completers and non-completers within each condi-
tion on baseline measures, all to3 all p4 .05. The only exception
was lower mean scores on the AST-D in CBM completers in the
control condition (relative to CBM non-completers in the Control
conditions, p¼ .005, ns after adjustment for multiple comparisons).
Importantly, in the per protocol sample there were no differences
between conditions in any baseline measures. Table 4 reports the
results of the main analyses.3 For the PHQ9 there was a main effect
of Time, F(3, 124.59)¼17.45, po .001, but no overall Time by Group
interaction, p¼ .10.The between-group differences were signiﬁcant
in favor of the positive condition following CBM and iCBT, po .05.
For the BDI-II there was a main effect of Time, F(3, 122.47)¼32.39,
po .001, that was qualiﬁed by a signiﬁcant interaction of Time by
Group, F(3, 122.47)¼4.28, po .01. The between-group difference in
favor of the positive condition was signiﬁcant following CBM,
po .05, but not following iCBT, p¼ .08. For the AST-D only the main
effect of Time was signiﬁcant, F(1, 85.30)¼26.49, po .001. The
between-group difference was not signiﬁcant. For the K10 there
was a main effect of Time, F(3, 122.88)¼37.72, po .001, and Group,
F(1, 43.39)¼4.19, po .05, that was qualiﬁed by a signiﬁcant Time
by Group interaction, F(3, 122.88)¼4.40, po .05. The between-
group differences in favor of the positive condition were signiﬁ-
cant following CBM and iCBT, po .01.
3.5. Primary and secondary outcomes at 3-month follow-up
Gains were maintained for all outcome measures collected at
the 3-month follow-up (i.e., there were no signiﬁcant changes
from post to follow-up on any measures), with no between-group
differences (see Tables 2 and 3).4
3.6. Clinically signiﬁcant change
Following the 1-week CBM phase, 61% of patients in the
positive condition evidenced clinically signiﬁcant change on the
BDI-II compared to 44% in the control condition. Clinically sig-
niﬁcant change following iCBT was 69% in the positive condition
and 50% in the control condition. The difference at both time
points was not signiﬁcant, χ2o3.5, p4 .05. Interestingly, mean
SoCT scores collected following the combined intervention were
inversely correlated with depression scores (PHQ9 r¼ .63, BDI-II
r¼ .59, po .001) and were signiﬁcantly higher in participants
evidencing clinically signiﬁcant change (M¼27.65, SD¼5.55) rela-
tive to those who did not (M¼24.34, SD¼5.26), t(64)¼2.38,
po .05. Clinically signiﬁcant change in anxiety scores (STAI)
following the combined intervention was observed for 38% of
the positive condition compared to 18% in the control condition, χ2
(1, 66)¼3.26, p¼ .07.
3.7. Diagnostic status at follow-up
Diagnostic interviews were conducted for all 33 participants in
the positive condition and 32/33 participants who completed the
3-month follow-up questionnaires in the control condition. 52%
(n¼17) of the positive condition and 56% (n¼18) of the control
condition (after they had completed the identical iCBT program for
depression) no longer met diagnostic criteria for any of the
disorders assessed at baseline (MDD, GAD, SP). 30% (n¼10) of
the positive condition and 19% (n¼6) of the control condition met
criteria for MDD. Comorbidity for the positive condition was as
follows: GAD only (n¼5, 15%), SP only (n¼1, 3%), MDD/GAD (n¼3,
9%), MDD/SP (n¼1, 3%), and MDD/GAD/SP (n¼5, 16%). Comorbid-
ity for the control condition was as follows: GAD only (n¼8, 25%),
MDD/GAD/SP (n¼5, 16%).
Table 3
Observed means (standard deviations) for secondary measures and within and between-group effect sizes in full sample.
Baseline Mean (SD) Post-iCBT Mean (SD) Within t(df)r Between t(df) 3 Month Mean (SD) Within t(df) r Between t(df)
T1 T3 ES (95% CI) T1, T3 ES (95% CI) T1, T2 T4 ES (95% CI) T3, T4 ES (95% CI) T3, T4
WHODAS
Positive
32.58 (9.30) 23.54 (9.16) 5.32 (2130.92)nn r¼ .43 .71 (1156.65) 24.87 (9.24) .74 (2129.09) r¼ .78 1.14 (1156.56)
.82 (.32–1.31) .17 ( .30 to .65) .08 ( .40 to .56) .28 ( .20 to .76)
WHODAS Control 33.05 (9.29) 25.17 (9.15) 4.79 (2131.88)nn r¼ .48 22.24 (9.12) 1.71 (2130.42) r¼ .44
.83 (.35–1.30) .21 ( .27 to .69)
RTQ Positive 40.67 (10.08) 28.84 (9.45) 7.09 (2133.37)nn r¼ .56 1.02 (1149.89) 28.13 (9.47) .41 (2131.62) r¼ .83 .81 (1149.80)
1.17 (.49–1.66) .25 ( .23 to .73) .04 ( .44 to .52) .19 ( .28 to .68)
RTQ Control 42.07 (9.60) 31.26 (9.44) 6.71 (2134.27)nn r¼ .34 30.03 (9.41) .71 (2132.77) r¼ .34
1.32 (.84–1.79) .14 ( .34 to .22)
STAI Positive 61.36 (10.56) 51.71 (10.41) 5.01 (2133.10)nn r¼ .57 1.22 (1158.08) 51.98 (10.44) .12 (2131.29) r¼ .63 .04 (1157.99)
.81 (.31–1.30) .29 ( .18 to .78) .01 ( .47 to .49) .01 ( .47 to .49)
STAI Control 63.61 (10.54) 54.86 (10.37) 4.70 (2134.04)nn r¼ .22 51.86 (10.33) 1.54 (2132.59) r¼ .52
1.01 (.53–1.48) .26 ( .22 to .74)
Note. T1¼Baseline, T3¼Post-CBMþ iCBT, T4¼3 month follow-up. WHODAS¼World Health Organization Disability Assessment Schedule-II; RTQ¼Repetitive Thinking
Questionnaire. STAI-T¼State Trait Anxiety Inventory-Trait; Within-group ES¼Cohen's d based on the formula: d¼t*SQRT[2(lr)/n]. N T1: Positive¼36, Control¼39; T3:
Positive¼32, Control¼34; T4: Positive¼33, Control¼33.
nn po .001.
3 Due to a system error, in the control condition 8 participants completed
1 session and 5 participants completed 2 sessions of the positive CBM in place of
the control CBM. The pattern of results remained unchanged when selecting out
these participants from the modiﬁed ITT analyses.
4 Note that data collected at 3-month follow-up contained 9 participants (n¼4
positive, n¼5 control) who did not complete any iCBT lessons and 4 participants
(n¼2 each group) who did not supply data post-iCBT.
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Table 4
Observed means (standard deviations) and within and between-group effect sizes for the CBM per protocol sample.
Baseline Mean
(SD)
Post-CBM Mean
(SD)
Within t(df) r Between t(df) Post-iCBT Mean
(SD)
Within t(df) r Between t(df) 3 Month Mean
(SD)
Within t(df) r Between t(df)
T1 T2 ES (95% CI) T1, T2 ES (95% CI) T1, T2 T3 ES (95% CI) T1, T3 ES (95% CI) T1,
T3
T4 ES (95% CI) T3, T4 ES (95% CI) T3,
T4
PHQ9 Positive 15.80 (5.51) 8.14 (6.35) 4.85 (3122.78)nn
r¼ .37
2.12 (1137.28)n 7.20 (4.94) 5.32 (3124.01)nn
r¼ .58
1.98 (1141.07)n 9.68 (6.14) 1.48 (3124.86)
r¼ .52
.14 (1109.19)
1.18 (.57–1.78) .55 ( .03 to 1.13) 1.09 (.46–1.71) .67 (.06–1.27) .25 ( .23 to .73) .09 ( .38 to .58)
PHQ9 Control 16.00 (4.97) 11.92 (7.02) 2.82 (3122.78) ns
r¼ .61
11.04 (6.06) 3.42 (3124.87)n
r¼ .03
9.05 (6.64) 1.08 (3125.15)
r¼ .27
.49 ( .06 to 1.04) .99 (.40–1.57) .22 ( .21 to .75)
BDI-II Positive 30.42 (8.04) 19.71 (8.22) 4.43 (3121.32)nn
r¼ .59
2.41 (1,96.79)n 14.20 (11.47) 6.53 (3122.17)nn
r¼ .35
1.75 (1101.82) 19.05 (11.68) 2.07 (3121.82)
r¼ .44
1.27 (191.90)
.87 (.26–1.47) .70 (.11–1.28) 1.66 (1.02–2.29) .57 ( .03 to
1.17)
.38 ( .04 to .92) .34 ( .14 to .83)
BDI-II Control 33.32 (10.66) 27.60 (12.78) 2.58 (3121.32) r¼ .69 20.73 (10.69) 5.73 (3122.76)n
r¼ .35
14.75 (12.94) 1.84 (3122.67)
r¼ .37
.40 ( .15 to .95) 1.36 (.77–1.94) .35 ( .13 to .83)
AST-D Positive 3.69 (1.05) 4.63 (.90) 3.11 (185.30)n r¼ .19 .97 (173.00)
.86 (.30–1.41) .27 ( .31 to
.85)
AST-D Control 3.21 (1.07) 4.38 (.88) 4.21 (185.31)nn r¼ .12
1.11 (.55–1.66)
K10 Positive 30.66 (5.73) 23.42 (4.79) 4.81 (3121.60)nn
r¼ .72
2.67 (1103.77)nn 18.35 (5.59) 7.87 (3122.53)nn
r¼ .60
3.10 (1111.21)nn 23.21 (6.48) 3.10 (3122.17)
r¼ .29
.16 (188.56)
.78 (.17–1.38) .88 (.29–1.46) 1.57 (.94–2.19) .90 (.29–1.50) .64 (.15–1.12) .14 ( .11 to .62)
K10 Control 32.60 (6.25) 29.48 (8.02) 2.26 (3121.60) r¼ .74 24.08 (6.78) 6.11 (3123.17)nn
r¼ .25
22.15 (7.98) .84 (3123.12) r¼ .53
.32 ( .23 to .87) 1.56 (.97–2.14) .14 ( .34 to .62)
Note. Between-group signiﬁcance values: nnpo .01, npo .05. Bonferroni adjusted within-group signiﬁcance values nnpo .001, npo .01. T1¼Baseline, T2¼Post-CBM, T3¼Post-CBMþ iCBT, T4¼3-month follow-up. PHQ9¼Patient
Health Questionnaire-9 item; BDI-II¼Beck Depression Inventory- 2nd Edition; K10¼Kessler Distress Scale – 10 item; AST-D¼Ambiguous Scenarios Test for Depression. Within-group ES¼Cohen's d based on the formula: d¼t*SQRT
[2(lr)/n]. N T1: Positive¼21, Control¼25; T2: Positive¼21, Control¼25; T3: Positive¼20, Control¼23; T4: Positive¼19, Control¼20.
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3.8. Post-hoc analyses of anhedonia
For the BDI-II anhedonia subscale (per protocol sample, follow-
ing Blackwell et al. (2015)) there was a main effect of time,
F(1,44)¼18.14, po .001 that was qualiﬁed by a signiﬁcant Time
by Group interaction, F(1,44)¼5.04, po .05. Anhedonia scores
decreased signiﬁcantly in the positive condition from pre-CBM
(M¼3.33, SD¼1.19) to post-CBM (M¼2.42, SD¼1.20) correspond-
ing to a medium effect (Cohen's d¼ .57, 95% CI¼ .01 to 1.15),
t(73)¼4.41. The decrease in anhedonia scores in the control
condition from pre-CBM (M¼3.32, SD¼1.65) to post-CBM
(M¼3.04, SD¼1.96) was not signiﬁcant, nor was the between-
group effect, Fo1.5, p4 .05.
3.9. Treatment acceptability
Treatment acceptability and program evaluation ratings are
reported in Table 1. There were no between-group differences in
ratings, all p4 .05.
4. Discussion
The current RCT sought to replicate the initial successful
application of imagery CBM delivered via the Internet without
face-to-face contact, and to establish whether positive imagery
CBM is superior to a CBM control version when delivered to
participants with a current major depressive episode. Similar to
our previous ﬁndings (Williams et al., 2013b) in the full sample we
found moderate-large within-group ESs for reductions in our
primary measures of depression (PHQ9, BDI-II) and secondary
measure of psychological distress (K10) in participants assigned to
the positive condition. However, contrary to prediction, moderate-
large within-group ESs were also observed for participants in the
control condition and there were no between-group differences in
outcomes in the full sample.
The lack of a differential effect between the two conditions
raises a number of important considerations. As previously noted
(Williams et al., 2013a), we chose a control condition that would
be closely matched to our active intervention in regards to the
structure of the task, imagery generation, repeated practice of a
computer task, and contact with the research team. The standard
structure of the ‘control’ condition employed in CBM interpreta-
tion bias studies has consisted of a 50/50 ratio of negative to
positive disambiguated training scenarios based on the assump-
tion that a speciﬁc learning contingency is not established under
these conditions. Yet, experimental and clinical studies have
recently converged to suggest that the crucial ‘ingredients’ of the
imagery CBM task are the presence of initial emotional ambiguity
in the training scenarios and the use of imagery (Clarke et al.,
2014a; Torkan et al., 2014). Therefore it is possible that the control
variant employed in the current trial represented a smaller ‘dose’
of CBM positive training, thus leading to positive therapeutic
effects observed in our CBM control group. Considering the
apparent importance of these two features the most appropriate
control conditions in future trials may therefore contain neither
emotional ambiguity nor use of imagery, in order to reduce the
extent to which a control condition contains too many of the
‘active ingredients’ of the CBM intervention.
The lack of between-group differences could also be attribu-
table to dilution of effects in the full sample. Further, having the
intervention delivered entirely remotely may have reduced levels
of task ﬁdelity (and thus a smaller signal to noise ratio in the data)
compared to studies in which training to task requirements was
provided in an initial face-to-face session (e.g., Lang et al., 2012;
Torkan et al., 2014). It is also possible that the sample recruited
was one in which it would have been particularly difﬁcult to detect
between-group differences: Blackwell et al. (2015) found super-
iority of a four-week Internet-delivered imagery CBM over an
active control only for participants with fewer than 5 episodes of
depression, which corresponds to only 16% of the sample in the
current RCT.
It is interesting that we found greater improvement in the
control condition than might be expected on the basis of previous
smaller-scale clinical studies (a mean reduction on the BDI-II from
pre to post-control intervention of 7.69 in the current trial,
compared to .54 for Lang et al., 2012 or 3.93 for Torkan et al.,
2014). The control condition in the current study was similar to
that used by Lang et al. (2012) in that the only difference from the
positive condition was that half of the training stimuli were
resolved positively and half were resolved negatively (although
the training paradigm in the current study was only one of three
used by Lang et al. (2012)). However, in the context of a clinical
trial in which participants are treatment-seeking individuals
believing they may be receiving an intervention to change their
thinking styles (which was not the case for Lang et al. (2012),
which was an experimental study), such a control condition may
perform differently (cf. Blackwell et al., 2015).
It is important to note that a shift in interpretation bias,
towards more positive interpretations of ambiguous information,
was observed in both conditions. As the induced shift in proces-
sing ambiguous information at least partially mediated the effect
of CBM training on depression symptoms in our previous RCT
(Williams et al., 2013b), it therefore may not be surprising that
equivalent reductions in primary symptom measures occurred in
both groups. The similar change on the AST-D in the per protocol
sample does not allow us to conclude that the differential
symptom outcome was mediated by changes in interpretive
bias, and thus it may be other factors, such as receiving more
practice in generating speciﬁcally positive imagery that contrib-
uted to the additional beneﬁt on symptoms of depression
conferred by the positive condition. Greater speciﬁcity in asses-
sing bias change via inclusion of a measure indexing a wider
range of depressogenic cognitions (Rohrbacher and Reinecke,
2014), or objective measurement of bias change, such as evidence
of violations of expectancy gathered by ERP responses from EEG
studies (Moser et al., 2012) might serve as useful additions in
future studies.
A strength of the current study is the inclusion of diagnostic
interviews conducted at 3-month follow-up. The majority of
participants in both groups no longer met diagnostic criteria for
any disorder that was assessed at baseline after completing the
same iCBT program for depression. Not only did diagnostic status
for the primary disorder of MDD change signiﬁcantly, but the
percentage of comorbid GAD and Social Phobia also reduced. The
combined intervention (in both conditions) also resulted in
signiﬁcant reductions in secondary outcome measures including
disability, repetitive negative thinking and trait anxiety, corre-
sponding to medium to large effect sizes.
In our per protocol sample (those who completed all seven
sessions of CBM and thus received the intended ‘dose’ of the
intervention) we did ﬁnd signiﬁcant between-group differences
from pre to post-CBM, which remained signiﬁcant after the
10-week iCBT program for the PHQ9 and K10. Further, and
consistent with a recent RCT of a four-week positive imagery
CBM intervention, in post-hoc analyses we found a signiﬁcant
advantage for the positive CBM intervention over the control
condition for anhedonia. The superiority of the positive over
control condition on symptom outcomes over the one-week
intervention in the per protocol sample is consistent with the
earlier small clinical studies that have shown superiority over an
active control. We note that the high rate of adherence in these
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previous studies is similar to the per protocol requirements (58%
completed all 7 positive CBM sessions) in the current study.
We have previously speculated that CBM may serve a prepara-
tory function for engagement in subsequent therapy, perhaps by
boosting motivation to engage in the schedule imposed by (Inter-
net) CBT (e.g. via boosting positive mood or behavioral engage-
ment directly; cf. Pictet et al., 2011); or by facilitating success with
certain CBT techniques (e.g., generating positive alternative
thoughts or anticipating success from behavioral tasks). Given
the minimal differences between the two conditions during the
CBM phase, it is encouraging to ﬁnd differential outcomes 10
weeks later after an identical iCBT program. While there was no
evidence for superiority of the positive condition in the longer-
term (i.e., 3 month follow-up), accelerating recovery is a useful
goal in itself. Qualitative feedback from our trial participants
suggests that CBM might facilitate cognitive re-appraisal even in
the absence of the explicit guided instruction used in CBT (e.g.,
‘The CBM program made me very aware of my negative thinking…. I
learned to not always expect the worst’). This raises the hypothesis
that people who have previously tried CBT but struggle with
explicit cognitive challenging tasks may beneﬁt from a CBM
module that targets this process implicitly through training. The
reduction in anhedonia over the one-week positive imagery CBM
observed in our per protocol sample is encouraging in adding
further support to the suggestion by Blackwell et al. (2015) that
imagery CBM may be a useful tool for treating anhedonia in
depression.
The current ﬁndings need to be considered in light of a number
of limitations. The absence of another control comparator makes it
difﬁcult to attribute the beneﬁcial effects solely to the interven-
tion. In a previous RCT employing highly similar recruitment and
delivery procedures (Williams et al., 2013b), we did not observe
any signiﬁcant changes in a wait-list control group following the
same 1-week CBM intervention phase where some non-speciﬁc
factors (e.g., contact with the research team) were matched. We
cannot exclude the possibility that symptom reductions reﬂected
the operation of a placebo effect or that clinical response mea-
sured at 3-month follow-up was a result of natural ﬂuctuations in
symptoms across time. However, the magnitude of the reductions
across all symptom measures suggests this explanation is unlikely.
Although the sample was comprised of individuals meeting
diagnostic criteria for depression (many of whom presented with
a history of depressive episodes and clinical comorbidities), it is
unknown whether the current results would generalize to more
severe patients not taking part in a research trial or to those with
other Axis I or II disorders not assessed in the current study.
Results of the per protocol analyses must also be interpreted with
caution given the reduced sample size in both groups after
selecting out those who completed all 7 CBM sessions, and the
fact that per protocol samples may lose some of the beneﬁts of
randomization, leading to increased risk of bias (e.g. participant
self-selection; Moher et al., 2010). Tracking the trajectory of
change across CBM sessions would inform our understanding of
the minimal ‘dose’ required to lead to therapeutic change and
therefore enable better understanding of what constitutes an
intervention ‘completer’.
In summary, although results did not support our primary
hypotheses, the lack of differential outcomes could possibly be
attributable to the active ingredients contained in our control
comparator. Inclusion of an alternative control group would enable
a more rigorous evaluation of this proposal. Results are encoura-
ging for both the standalone beneﬁts of the one-week imagery
CBM module and the combined CBM and iCBT intervention, when
all 7 sessions of CBM are completed (as in our per protocol
sample). Given that between-group differences were found in
the per protocol sample but not in the full sample, enhancing
adherence to the CBM sessions or identifying people who may be
less likely to complete (and therefore beneﬁt) should be a focus of
future research. Results will inform further clinical trials of the
combined intervention and basic research investigating the range
of potential treatment mechanisms. How best to combine CBM
and iCBT approaches to optimize the overall treatment package is
an important question for further research.
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